These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38436501)

  • 1. Multi-proteomic analyses of 5xFAD mice reveal new molecular signatures of early-stage Alzheimer's disease.
    Lee S; Jang KI; Lee H; Jo YS; Kwon D; Park G; Bae S; Kwon YW; Jang JH; Oh YS; Lee C; Yoon JH
    Aging Cell; 2024 Jun; 23(6):e14137. PubMed ID: 38436501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
    Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
    Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal and Sex-Linked Protein Expression Dynamics in a Familial Model of Alzheimer's Disease.
    Blasco Tavares Pereira Lopes F; Schlatzer D; Wang R; Li X; Feng E; Koyutürk M; Qi X; Chance MR
    Mol Cell Proteomics; 2022 Sep; 21(9):100280. PubMed ID: 35944844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
    Gurel B; Cansev M; Sevinc C; Kelestemur S; Ocalan B; Cakir A; Aydin S; Kahveci N; Ozansoy M; Taskapilioglu O; Ulus IH; Başar MK; Sahin B; Tuzuner MB; Baykal AT
    J Alzheimers Dis; 2018; 61(4):1399-1410. PubMed ID: 29376847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-biased hippocampal pathology in the 5XFAD mouse model of Alzheimer's disease: A multi-omic analysis.
    Bundy JL; Vied C; Badger C; Nowakowski RS
    J Comp Neurol; 2019 Feb; 527(2):462-475. PubMed ID: 30291623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
    J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer's Disease.
    Delgado-Peraza F; Nogueras-Ortiz CJ; Volpert O; Liu D; Goetzl EJ; Mattson MP; Greig NH; Eitan E; Kapogiannis D
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
    Bai B; Wang X; Li Y; Chen PC; Yu K; Dey KK; Yarbro JM; Han X; Lutz BM; Rao S; Jiao Y; Sifford JM; Han J; Wang M; Tan H; Shaw TI; Cho JH; Zhou S; Wang H; Niu M; Mancieri A; Messler KA; Sun X; Wu Z; Pagala V; High AA; Bi W; Zhang H; Chi H; Haroutunian V; Zhang B; Beach TG; Yu G; Peng J
    Neuron; 2020 Mar; 105(6):975-991.e7. PubMed ID: 31926610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle proteome unveils cathepsin B connection to Alzheimer's disease pathogenesis.
    Yuyama K; Sun H; Fujii R; Hemmi I; Ueda K; Igeta Y
    Brain; 2024 Feb; 147(2):627-636. PubMed ID: 38071653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Signaling of Dual-Specificity Phosphatase 4 (DUSP4) in Alzheimer's Disease.
    Wang E; Pan AL; Bagchi P; Rangaraju S; Seyfried NT; Ehrlich ME; Salton SR; Zhang B
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer's disease.
    Aladeokin AC; Akiyama T; Kimura A; Kimura Y; Takahashi-Jitsuki A; Nakamura H; Makihara H; Masukawa D; Nakabayashi J; Hirano H; Nakamura F; Saito T; Saido T; Goshima Y
    Neurobiol Dis; 2019 Dec; 132():104603. PubMed ID: 31494281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.
    Do Carmo S; Crynen G; Paradis T; Reed J; Iulita MF; Ducatenzeiler A; Crawford F; Cuello AC
    Mol Neurobiol; 2018 Apr; 55(4):3451-3476. PubMed ID: 28502044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer's pathology.
    Kumar P; Goettemoeller AM; Espinosa-Garcia C; Tobin BR; Tfaily A; Nelson RS; Natu A; Dammer EB; Santiago JV; Malepati S; Cheng L; Xiao H; Duong DD; Seyfried NT; Wood LB; Rowan MJM; Rangaraju S
    Nat Commun; 2024 Apr; 15(1):2823. PubMed ID: 38561349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.